Can the Occurence of Autoantibody to Protein Disulfide Isomerase be a Marker for the Development of Hepatitis?

(1)自发性遗传性肝炎和肝癌的Long Evans Cinnamon （LEC）大鼠具有针对肝微粒体蛋白的自身免疫抗体，尤其是分子量为56kD和55kD的蛋白。这些抗体与LEC大鼠急性致死性肝炎有关。nh2末端氨基酸序列分析表明，这两个抗原蛋白分别为蛋白二硫异构酶（PDI）和钙网蛋白（calreticulin）。PDI是一种主要的自身免疫抗原蛋白。(2)采用免疫印迹法和放射免疫法观察大鼠给药后PDI自身抗体的发生情况。用d -半乳糖胺、对乙酰氨基酚和马来酸二乙酯预处理、四氯化碳预处理的大鼠抗pdi自身抗体检测频率较高。单用四氯化碳、对乙酰氨基酚、对乙酰氨基酚、多酚或dl -蛋氨酸组抗体阳性率较低。单独用马来酸二乙酯处理的大鼠未检测到抗pdi抗体。虽然抗pdi自身抗体产生的机制尚不清楚，但抗pdi抗体的产生与血清GPT活性高有关。(3) LEC大鼠口服免疫抑制剂环孢素a和促进铜排泄的d -青霉胺23周。测定死亡率、血液生化指标及血清抗pdi抗体滴度。在对照组LEC大鼠中，8只大鼠中有4只在20周龄前死亡。在环孢素a治疗组的7只大鼠中，只有1只在20周龄时死亡。大鼠经d -青霉胺处理后，肝炎临床症状的发展受到抑制，所有大鼠均存活。环孢素a治疗的大鼠血液生化指标与对照组相似。未存活大鼠抗pdi抗体滴度高于存活大鼠。这些发现表明抗pdi抗体与致死率有关，但与LEC大鼠血液生化参数测量的肝炎的明显发生和进展无关。少

(1) Long Evans Cinnamon (LEC) rats, showing spontaneous hereditary hepatitis and hepatic carcinoma, were found to possess autoimmune antibodies to liver microsomal proteins, particularly to proteis with the molecular weight of 56kD and 55kD.The antibodies occurred in association with acute lethal hepatitis in the LEC rats. These two antigenic protein were revealed to be protein disulfide isomerase (PDI) and calreticulin, respectively, from NH2-terminal amino acid sequence analysis. PDI was a major autoimmune antigenic protein.(2) The occurrence of an autoantidody to PDI in rats after administration of various hepatotoxic drugs was investigated by immunoblotting and radiommunoassay. The anti-PDI autoantibody was detected with high frequency in rats pretreated pretreated with D-galactosamine, acetaminophen with diethylmaleate, and carbon tetrachloride with diethylmaleate. The antibody-positive rate was relatively low in the groups of rats given carbon tetrachloride, acetaminophen, acetam … More inophen or DL-ethionine alone. The anti-PDI antibody was not detected in rats treated with diethylmaleate alone. Although the mechanism of the production of the anti-PDI autoantibody is unclear, the occurrence of anti-PDI antibody correlated with high serum GPT activities.(3) Cyclosporin-A,an immunosuppressant, and D-penicillamine, which promotes copper excretion, were orally administered to LEC rats for 23 weeks. Mortality, blood biochemical parameters and the titer of serum anti-PDI antibody were measured. In control LEC rats, four of eight rats died bifore 20-weeks-old. Only one of seven rats in the cyclosporin-A-treated group died at the age of 20 weeks. When rats were treated with D-penicillamine, the development of clinical signs of hepatitis was inhibited, and all rats survived. Cyclosporin-A-treated rats showed increases in blood biochemical parameters similar to those in control rats. The titer of anti-PDI antibody in control rats was higher in the non-survivors than in the survivors. These findings suggest the association of the anti-PDI antibody with lethality, but not with the apparent development and progression of hepatitis as measured by blood biochemical parameters in LEC rats. Less